The Dutch Cancer Society (KWF) has awarded 8 grants to Radboudumc researchers. We congratulate them with this funding and wish them success with their great work.
Research project:Research project: 177Lu-PSMA Radioligand Therapy for Salivary Gland Cancer.
Carla van Herpen, theme Rare cancers, RIHS
Approved budget: € 656,845
Young Investigator grant:Research project: Fear of progression in advanced cancer patients with prolonged survival on ongoing cancer treatment in an era of personalized medicine.
Jose Custers, theme Women's cancers, RIHS
Approved budget: € 424,731
ConsortiumResearch project: Timely detection of breast cancer: the interplay of mammographical characteristics, growth rate and clinicopathological features in predicting the outcome.
Mireille Broeders, theme Women's cancers, RIHS
Approved budget: € 730,260
Unique high risk projects:Research project: Boosting intraperitoneal NK cell therapy in ovarian cancer through mRNA mediated IL-15 expression.
Roland Brock, theme Nanomedicine, RIMLS.
Approved budget: € 116.502
Research project: PROACTING: Predicting neoadjuvant treatment response with deep learning.
Francesco Ciompi, theme Tumors of the digestive tract, RIHS
Approved budget: € 199,959
Research project: Development of a minimal invasive surgical treatment for skeletal metastases.
Ingrid van der Geest, theme Reconstructive and regenerative medicine, RIHS
Approved budget: € 146,062
Research project: Correlation between CT perfusion, genomics and immunohistopathology to predict and evaluate therapy response in patients with pancreatic ductal adenocarcinoma.
John Hermans, theme Rare cancers, RIHS
Approved budget: € 229,405
Research project: COMPRAYA: Landelijke infrastructuur om gezondheidsuitkomsten in kaart te brengen en interventiestudies uit te voeren onder jongvolwassenen met kanker (AYA's).
Winette van der Graaf, theme Rare cancers, RIHS
Approved budget: € 2,790,721
Go to the Dutch Cancer Society website (KWF).
Related news items
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more
Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.29 July 2020
These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.read more
Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process28 July 2020
''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.read more